StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.66−0.26 (-6.63%)

Close on Nov 16, 2026Market cap $47.03MP/E –Yield –

Earnings

Clene's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 11, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$56.00K
+273.3% on a year earlier
EPS, Q3 FY2026
$0.05
-$0.85 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Clene's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 11, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026before the open$56.00K+273.3%$0.05Release
Q2 FY2026ended Jun 30, 2026Aug 14, 2026before the open$90.00K+233.3%-$1.08Release
Q1 FY2026ended Mar 31, 2026May 14, 2026before the open$15.00K–-$0.69Release
Q4 FY2025ended Dec 31, 2025Mar 12, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025before the open$15.00K-82.8%-$0.85Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open$27.00K-70.3%-$0.78Release
Q1 FY2025ended Mar 31, 2025May 7, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Mar 24, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024before the open$87.00K-19.4%-$1.22Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024before the open$91.00K-66.2%-$1.06Release
Q1 FY2024ended Mar 31, 2024May 8, 2024before the open$73.00K-31.8%-$0.09Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Clene has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Clene puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Clene filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. News
  4. Results
  5. Update
  6. Update
  7. Results
  8. News
  9. Update
  10. Results
  11. News
  12. News
  13. News
  14. Update
  15. News

See a number that looks wrong?